Susanne Schaffert - 12 Jul 2022 Form 3 Insider Report for Rubius Therapeutics, Inc.

Role: Director
Signature: /s/ Maiken Keson-Brookes, as Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 12 Jul 2022
Net transactions value: $0
Form type: 3
Filing time: 19 Jul 2022, 17:54:11 UTC
Next filing: 01 Aug 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney